That said, eliminating the ability of the virus to infect human cells, used as a drug, and giving the immune system time to adapt and complete the elimination of the virus and in the combined process reducing the peak viral load and ability of infected people to spread the virus to others is the target here...
It is not, IMO a one time cure... IMO it would have a huge market for use every time people get a new infection. It is non toxic and safe from what we know so far...and intrinsically safe by design kind of like a condom LOL.
So big pharma would love it.
There is no "cure" for mutating, adapting on the fly viruses that are already spread world wide.. and mutating on demand among a world full of antivaxers.
If by cure, you mean eliminating all traces of the virus in days, yes. But Covid 19 has already proven it can adapted to our Immune systems and re-cloak itself as something just new enough to get a grip on us every new generation....
In with case the BIXT drug would be safe enough to use on demand like water for dehydration.
Recent BIXT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:43:10 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 03:09:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 01:05:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 01:02:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 10:34:21 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 10/02/2023 03:36:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/26/2023 09:04:03 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 09/21/2023 02:53:48 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/19/2023 05:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 07:09:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 07:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 06:45:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 01:15:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2023 06:07:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/07/2023 01:23:13 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 06/30/2023 08:58:38 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM